Senseera’s is a liquid biopsy company developing a new genetration of blood tests, to advance human health, and enhance early detection of cancer
Liquid Biopsy Vision
A single inexpensive blood test for detection, monitoring, and better treatment of a wide range of human diseases
Activity In The Consortium
Senseera will generate genome-wide level data from its cfChIP-seq technology, and collaborate to advance liquid biopsy from a central lab model to point of care device